EURASIAN JOURNAL OF MEDICINE, cilt.47, sa.2, ss.79-84, 2015 (ESCI İndekslerine Giren Dergi)
Objective: Patients with resistant hypertension are at increased risk for cardiovascular events. Mean platelet volume (MPV) is an accepted biomarker of platelet activation and considered as a risk factor for cardiovascular disease. The aim of this study was to determine whether MPV levels are higher in resistant hypertensive (RHTN) patients than in controlled hypertensive (CHTN) patients and healthy normotensive controls.